John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Inovio Pharmaceuticals
INO
$133M
| $700K | ﹤0.01% |
14,588
+2,048
| +16% | +$124K |
|
1877
HealthStream
HSTM
$844M
| $699K | ﹤0.01% |
28,942
-30,136
| -51% | -$781K |
|
|
LITS
1878
Lite Strategy Inc
LITS
$35.7M
| $698K | ﹤0.01% |
13,214
+3,283
| +33% | +$202K |
|
1879
Hyster-Yale Materials Handling
HY
$624M
| $697K | ﹤0.01% |
11,256
+3,322
| +42% | +$207K |
|
1880
Bridgewater Bancshares
BWB
$589M
| $696K | ﹤0.01% |
66,011
-6,214
| -9% | -$71.8K |
|
|
CIVI
1881
DELISTED
Civitas Solutions, Inc.
CIVI
| $696K | ﹤0.01% |
39,740
-19,718
| -33% | -$294K |
|
1882
Ameris Bancorp
ABCB
$5.74B
| $695K | ﹤0.01% |
+21,952
| New | +$895K |
|
1883
PUT
Ball Corp
BALL
$17B
| $694K | ﹤0.01% |
15,100
-40,500
| -73% | -$1.89M |
|
1884
CALL
Dick's Sporting Goods
DKS
$11.1B
| $693K | ﹤0.01% |
22,200
+5,100
| +30% | +$177K |
|
1885
Stellantis
STLA
$19.8B
| $693K | ﹤0.01% |
47,900
-63,410
| -57% | -$1.02M |
|
1886
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $692K | ﹤0.01% |
+4,121
| New | +$769K |
|
1887
Ferrari
RACE
$74.1B
| $692K | ﹤0.01% |
6,960
-4,540
| -39% | -$510K |
|
1888
Mistras Group
MG
$605M
| $691K | ﹤0.01% |
48,045
-6,449
| -12% | -$113K |
|
1889
CALL
Union Pacific
UNP
$184B
| $691K | ﹤0.01% |
5,000
-84,000
| -94% | -$12.4M |
|
1890
i3 Verticals
IIIV
$306M
| $690K | ﹤0.01% |
28,631
-83,086
| -74% | -$1.74M |
|
|
LUMO
1891
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $690K | ﹤0.01% |
50,473
-3,215
| -6% | -$56.6K |
|
|
OSG
1892
DELISTED
Overseas Shipholding Group Inc.
OSG
| $690K | ﹤0.01% |
415,707
-85,078
| -17% | -$216K |
|
|
X
1893
CALL
DELISTED
US Steel
X
| $689K | ﹤0.01% |
37,800
-240,000
| -86% | -$6.01M |
|
1894
PUT
Eaton
ETN
$159B
| $687K | ﹤0.01% |
10,000
-14,800
| -60% | -$1.11M |
|
|
EGL
1895
DELISTED
Engility Holdings, Inc.
EGL
| $685K | ﹤0.01% |
24,054
+15,300
| +175% | +$476K |
|
1896
Grupo Aval
AVAL
$6.58B
| $684K | ﹤0.01% |
+115,971
| New | +$795K |
|
|
PPL
1897
PUT
PPL Corp
PPL
$26.3B
| $683K | ﹤0.01% |
24,100
-96,100
| -80% | -$2.92M |
|
1898
Cass Information Systems
CASS
$734M
| $682K | ﹤0.01% |
12,884
-12,816
| -50% | -$691K |
|
|
USG
1899
DELISTED
Usg
USG
| $682K | ﹤0.01% |
15,987
-13,899
| -47% | -$595K |
|
1900
PUT
TE Connectivity
TEL
$58.3B
| $681K | ﹤0.01% |
+9,000
| New | +$693K |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.